Company Filing History:
Years Active: 2021
Title: Sabine Schlecht: Innovator in Vaccine Development
Introduction
Sabine Schlecht is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of vaccine development through her innovative research and patents. Her work focuses on the use of replication-deficient RNA viruses as vaccines, which has the potential to revolutionize immunization strategies.
Latest Patents
Sabine Schlecht holds a patent for "Replication-deficient RNA viruses as vaccines." This invention involves a genome-replication-deficient and transcription-competent negative-strand RNA virus. It can be utilized for the expression of transgenes, particularly in vaccine development. The patent describes a recombinant Sendai virus that contains a viral genome with a mutation in the gene P. This mutation leads to a loss of replication capacity while maintaining secondary transcription capabilities. The invention also includes a nucleocapsid of the Sendai virus, a genome of the Sendai virus, and a DNA molecule coding for the genome and/or antigenome of the Sendai virus. Additionally, it outlines a pharmaceutical composition containing the Sendai virus, nucleocapsid, or viral genome as an active substance, emphasizing its medical use as a vaccine.
Career Highlights
Sabine Schlecht is affiliated with the Max Planck Society for the Advancement of Science, where she conducts her research. Her work has garnered attention for its innovative approach to vaccine development, showcasing her expertise in the field.
Collaborations
Some of her notable coworkers include Wolfgang J. Neubert and Sascha Bossow. Their collaborative efforts contribute to the advancement of research in vaccine technology.
Conclusion
Sabine Schlecht's contributions to the field of vaccine development through her innovative patents highlight her role as a leading inventor. Her work with replication-deficient RNA viruses has the potential to significantly impact public health and immunization practices.